Roc Oil Company bids SEK 58.7/sh for Tethys Oil Offer in-line with ABGSC valuation, independent comm...
FY'24 org. growth outlook downgraded... ...now expecting 5-10% org.
Biovica records consecutive quarterly IVD test sales growth of 40-50%, with good prospects ahead.
Redeye comments on the closing of the financing agreement with Pollen Street, securing SEK600m in in...
Redeye leaves a note following Coegin’s recent announcements of a signed Joint Development Agreement...
Biovica records IVD test sales in Q1 of SEK 0.62m, which is 50% above the previous quarter (Q4) and ...
Marimekko’s CMD offered more insights into the company’s SCALE strategy for 2023-2027 and its progre...
Redeye comments on the recent announcement of Sleep Cycle's partnership with MyFitnessPal, the leadi...
The new contract with a cardiology clinic includes over 1,300 Medicare patients and the progress str...
Q-linea has signed S.C. Mecro System SRL as a distributor for Romania, which is part of an attractiv...
Redeye provides a brief comment on the changes to CLS’ board of directors.
A niched construction company focused on the green transition Smart project selection, and a variabl...
Redeye comments on Vitec carrying out a directed share issue of cSEK1.
Redeye was surprised by today's announcement about CEO Christoffer Abramson stepping down, effective...
Scanfil changes reporting segments to geographical units in 2025.
Verve Group’s Q224 figures clearly show the benefit of its strategic focus on privacy-first targeted...
Redeye endorses SenzaGen’s new grant from RIFM, valued at SEK3.
Cantargia söker finansiering för att inleda en fas 2b-studie med antikroppen nadunolimab på patiente...
Marknadsbearbetningen fortskrider Nettoomsättningen ökade med 5,9 procent, vilket var en lägre öknin...
Bolaget har påverkats av en svag solmarknad, vilket resulterat i en 20%-ig nedgång jämfört med 2023.
